IFF Expands Latin America Footprint with New Enzyme Hub and Applications Lab in Brazil
IFF Expands Production and Innovation Capabilities in Latin America with New Enzyme Hub and Applications Laboratory Global ingredients and biosciences leader IFF is strengthening its footprint in Latin America through a strategic expansion designed to boost production capacity, innovation, and…
HIMSS 2026: Taiwan Showcases AI Healthcare Innovations
Taiwan Excellence Pavilion Debuts at HIMSS 2026 with Practical AI, Digital Healthcare Platforms, and Medical-Grade Computing Taiwanese healthcare technology innovators made a strong impression at the HIMSS 2026, introducing deployment-ready artificial intelligence solutions, digital care platforms, and medical-grade computing systems…
Dallas Nephrology Associates to Receive 2026 Burl Osborne Award
National Kidney Foundation to Honor Dallas Nephrology Associates with 2026 Award Dallas Nephrology Associates (DNA) has been selected to receive the prestigious Burl Osborne Award at the 2026 Bonne Santé event hosted by the National Kidney Foundation (NKF). The recognition…
TIXiMED: Oral TIX100 Prevents Post-GLP-1 Weight Regain in Preclinical Study
TIXiMED Reports Promising Preclinical Results for Oral TIX100 in Preventing Weight Regain After GLP-1 Therapy TIXiMED a clinical-stage pharmaceutical company focused on developing innovative treatments for diabetes and metabolic diseases, has announced encouraging new preclinical findings for its investigational oral…
InterSystems Appoints Dr. Tim Ferris as Vice President of Healthcare Practice
InterSystems Appoints Former NHS and Mass General Leader Dr. Tim Ferris as Vice President, Healthcare Practice InterSystems, a creative data technology provider powering more than one billion health records globally, today announced the appointment of Tim Ferris, M.D., as Vice…
First Patient Dosed in Emalex Biosciences’ Expanded Access Program for Investigational Tourette Syndrome Therapy
First Patient Dosed in Emalex Biosciences’ Expanded Access Program for Investigational Tourette Syndrome Therapy Emalex Biosciences today announced that the first patient was dosed in its Expanded Access Program for ecopipam, an investigational first-in-class D1 receptor antagonist in development for…
Innovaccer Launches Flow Capture to Bring Autonomous Coding to the Frontlines of U.S. Healthcare
Innovaccer Launches Flow Capture, Bringing Autonomous Coding to the Frontlines of American Healthcare Innovaccer, the leading healthcare AI company, launched Flow Capture, an autonomous medical coding solution designed to eliminate one of the most persistent bottlenecks in American healthcare: manual…
Fierce Healthcare Names SpotitEarly a “Fierce 15” Company of 2026
Fierce Healthcare Names SpotitEarly a “Fierce 15” Company of 2026 SpotitEarly, a multi-cancer early detection startup that uses AI and trained canines to identify cancer odor signatures in breath samples, today announced that Fierce Healthcare has named it as one…
New Real-World Evidence Study Shows Leva® Pelvic Health System Significantly Improves Fecal Incontinence in Women
New Real-World Evidence Study Shows Leva® Pelvic Health System Significantly Improves Fecal Incontinence Symptoms in Women Axena Health, Inc., a women’s health company redefining the standard of care for pelvic health through clinically proven, non-invasive treatments, today announced the publication of a…
NRC Health Approves $60M Share Repurchase Plan
NRC Health Announces $60 Million Share Repurchase Authorization National Research Corporation, doing business as NRC Health, has announced that its Board of Directors has approved a new stock repurchase program that allows the company to buy back up to $60…
Anthem Partners with Athens Orthopedic Clinic to Expand Orthopedic Care
Anthem, Athens Orthopedic Clinic Partner to Expand Orthopedic Access in Northeast Georgia Anthem Blue Cross and Blue Shield of Georgia has entered into a strategic partnership with Athens Orthopedic Clinic to broaden access to orthopedic services for patients across Northeast…
GoodRx Expands Employer-Sponsored Access to Zepbound KwikPen
GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen® GoodRx the leading platform for prescription savings in the U.S., today announced employer-sponsored access to Zepbound® (tirzepatide) KwikPen® (for single-patient-use) through GoodRx Employer Direct. As one of Lilly’s Employer Connect independent program administrators, GoodRx…